 | |
| Clinical data | |
|---|---|
| Other names | MDBU; 3,4-Methylenedioxy-N-butylamphetamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methylenedioxybutylamphetamine (MDBU or3,4-methylenedioxy-N-butylamphetamine) is a lesser-knowndrug.[1] It is also theN-butyl derivative of3,4-methylenedioxyamphetamine (MDA).[1] MDBU was first synthesized byAlexander Shulgin.[1] In his bookPiHKAL, the minimum dose is listed as 40 mg, and the duration unknown.[1] MDBU produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDBU.[1]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |
